SCHEMBL16166336

SCHEMBL16166336

CCCCOC(=O)NCCN=[N+]=[N-]

nearest known ligand 0.57

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ACHE P22303 14/20 0.57
EPHX1 P07099 1/20 0.42
EPHX2 P34913 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23137391 0.94 ACHE (0.51) ACHEEPHX1EPHX2
SCHEMBL30354527 0.92 ACHE (0.60) ACHEEPHX1EPHX2
SCHEMBL23607511 0.87 ACHE (0.66) ACHEEPHX1
SCHEMBL30080469 0.84 ACHE (0.51) ACHEEPHX1EPHX2
SCHEMBL19513091 0.84 ACHE (0.58) ACHEEPHX1EPHX2
SCHEMBL30080289 0.83 ACHE (0.54) ACHEEPHX1EPHX2
SCHEMBL31290254 0.83 ACHE (0.47) ACHEEPHX2
SCHEMBL24758685 0.83 GLA (0.41) ACHE
SCHEMBL23138402 0.83 ACHE (0.46) ACHE
SCHEMBL19513165 0.80 EPHX2 (0.51) ACHEEPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2875017-A1 DERIVATIVES OF 1-(SUBSTITUTED SULFONYL)-2-AMINOIMIDAZOLINE AS ANTITUMOR AND ANTIPROLIFERATIVE AGENTS ONCOARENDI THERAPEUTICS SP. Z.O.O. (PL) 2015-05-27 EP disclosed
WO-2014167446-A1 DERIVATIVES OF 1-(SUBSTITUTED SULFONYL)-2-AMINOIMIDAZOLINE AS ANTITUMOR AND ANTIPROLIFERATIVE AGENTS OncoArendi Therapeutics Sp. z o.o. (PL) 2014-10-16 WO disclosed